Mandana Nikpour, Ph.D.
Affiliations: | 2011 | University of Toronto, Toronto, ON, Canada |
Area:
Medicine and Surgery, Public HealthGoogle:
"Mandana Nikpour"Cross-listing: PHTree
Parents
Sign in to add mentor| Murray B. Urowitz | grad student | 2011 | University of Toronto | |
| (Identifying and Quantifying Dynamic Risk Factors for Coronary Artery Disease in Systemic Lupus Erythematosus.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Golder V, Kandane-Rathnayake R, Louthrenoo W, et al. (2024) Comparison Of Attainment And Protective Effects Of Lupus Low Disease Activity State In Patients With Newly Diagnosed Versus Established SLE. The Journal of Rheumatology |
| Katsumata Y, Inoue E, Harigai M, et al. (2024) Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study. Annals of the Rheumatic Diseases |
| Nielsen W, Strand V, Simon LS, et al. (2024) OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set. Seminars in Arthritis and Rheumatism. 65: 152380 |
| Cho J, Shen L, Huq M, et al. (2023) Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study. The Lancet. Rheumatology. 5: e584-e593 |
| Connelly K, Kandane-Rathnayake R, Hoi A, et al. (2022) Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study. The Lancet. Rheumatology. 4: e831-e841 |
| Kandane-Rathnayake R, Golder V, Louthrenoo W, et al. (2022) Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study. The Lancet. Rheumatology. 4: e822-e830 |
| Ross L, Proudman S, Walker J, et al. (2022) Evaluation of patient and physician assessments of gastrointestinal disease activity in systemic sclerosis. The Journal of Rheumatology |
| Kandane-Rathnayake R, Louthrenoo W, Hoi A, et al. (2022) 'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study. Arthritis Research & Therapy. 24: 70 |
| Jerjen R, Nikpour M, Krieg T, et al. (2022) Systemic sclerosis in adults. Part I: Clinical features and pathogenesis. Journal of the American Academy of Dermatology |
| Hao Y, Oon S, Ji L, et al. (2021) Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohort. Clinical Rheumatology |